Shock wave therapy is a non-invasive treatment used in wide areas of medical field, such as urology, cardiology, orthopedics, and physical therapy, among others. It is an alternative for orthopedic ...

People walk into physiotherapy clinics with all kinds of expectations. Some have been managing discomfort for months. Others want to return to a spot they love. Another group may simply ...

With the number of bogus remedies and treatments floating around, claiming to provide relief for various ailments, the FDA really has its work cut out for it. I mean, can you imagine trying to wade ...

FDA approves shockwave therapy for diabetic foot ulcers. The FDA has approved the Dermapace System for treatment of chronic, full-thickness diabetic foot ulcers. The US Food & Drug Administration (FDA ...

Today, the U.S. Food and Drug Administration permitted the marketing of the Dermapace System, the first shock wave device intended to treat diabetic foot ulcers. "Diabetes is the leading cause of ...

ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model ...

At Limitless Evolution, we focus on restoring function instead of masking symptoms. ReGen Medical RCT helps us support real healing with non-surgical, drug-free technology that works with the body.” — ...

SANTA CLARA, Calif., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc., a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified ...

The FDA on Dec. 28 permitted the marketing of Sanuwave’s Dermapace System to treat adults with diabetic foot ulcers. Here are three things to know. 1. The Dermapace System is an external shock wave ...

Shockwave Medical specializes in developing and commercializing medical devices using IVL technology for treating calcified plaque in vascular and heart valve diseases. The company has achieved ...

As an adjunct to bypass surgery for ischemic cardiomyopathy, a cardiac shockwave therapy aimed at regenerating ischemic myocardium boosted left ventricular ejection fraction (LVEF) and physical ...

In a deal that might as well be termed a heart-to-heart, Shockwave Medical has made a bid to combine Neovasc’s cardiac device business with its own. Shockwave has offered up $27.25 in upfront cash for ...